メタ情報
| meta description平均長 | 558.61 |
|---|
| OGPありページ数 | 18 |
|---|
| Twitterカードありページ数 | 18 |
|---|
HTML言語 分布
| キー | 割合 |
|---|
| en-us | 33.33% |
| de-de | 16.67% |
| es-es | 11.11% |
| it-it | 11.11% |
| ja | 11.11% |
| zh-cn | 11.11% |
| fr-fr | 5.56% |
内部リンク分析(Internal)
| ユニーク内部リンク数 | 138 |
|---|
| ページあたり内部リンク平均 | 50.94 |
|---|
連絡先候補(Contacts)
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| SHAREHOLDER | 1 |
| years | 1 |
| CEO | 1 |
| has | 0.923049 |
| companies | 0.833333 |
| experience | 0.833333 |
| DIRECTOR | 0.666667 |
| und | 0.627491 |
| prodotti | 0.54811 |
| dermal | 0.534397 |
| skin | 0.5 |
| non | 0.5 |
| large | 0.5 |
| Founder | 0.5 |
| over | 0.5 |
| thirty | 0.5 |
| senior | 0.5 |
| management | 0.5 |
| Managing | 0.5 |
| Director | 0.5 |
| GmbH | 0.5 |
| industry | 0.5 |
| die | 0.5 |
| LSC | 0.485627 |
| including | 0.475688 |
| applications | 0.456357 |
| other | 0.456357 |
| una | 0.438488 |
| delivery | 0.437234 |
| global | 0.437234 |
| products | 0.416667 |
| pharmaceutical | 0.342268 |
| patent | 0.342268 |
| held | 0.339777 |
| its | 0.339777 |
| product | 0.339777 |
| Inc | 0.333333 |
| care | 0.333333 |
| Field | 0.333333 |
| founded | 0.333333 |
| firm | 0.333333 |
| Biotech | 0.333333 |
| Biopharma | 0.333333 |
| leadership | 0.333333 |
| Xiidra | 0.333333 |
| international | 0.333333 |
| principal | 0.333333 |
| mid | 0.333333 |
| cap | 0.333333 |
| various | 0.333333 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Director | Managing | 2.967103 | 24 |
| DIRECTOR | SHAREHOLDER | 2.730529 | 32 |
| management | positions | 2.615074 | 18 |
| CEO | Founder | 2.54778 | 26 |
| Francisco | San | 2.542343 | 16 |
| issued | pending | 2.542343 | 16 |
| cap | mid | 2.542343 | 16 |
| ADVISOR | INDEPENDENT | 2.542343 | 16 |
| delivery | dermal | 2.447931 | 28 |
| Care | Skin | 2.33204 | 20 |
| commercial | success | 2.317965 | 12 |
| GmbH | Managing | 2.281192 | 18 |
| Director | GmbH | 2.281192 | 18 |
| large | mid | 2.278079 | 16 |
| Bay | Francisco | 2.158757 | 12 |
| Field | founding | 2.105299 | 10 |
| Field | partner | 2.105299 | 10 |
| Bozicevic | Field | 2.105299 | 10 |
| Connetics | Corporation | 2.099947 | 8 |
| Laboratory | Skin | 2.057856 | 12 |
| owned | wholly | 2.048601 | 8 |
| patent | pending | 2.031841 | 14 |
| experience | years | 2.023968 | 26 |
| cap | global | 2.013815 | 16 |
| over | thirty | 2.013815 | 16 |
| biotechnology | company | 2.00267 | 8 |
| founding | partner | 2.00267 | 8 |
| Bozicevic | partner | 2.00267 | 8 |
| Francis | LLP | 2.00267 | 8 |
| BFF | healthcare | 2.00267 | 8 |
| building | focused | 2.00267 | 8 |
| building | portfolios | 2.00267 | 8 |
| portfolios | start | 2.00267 | 8 |
| start | ups | 2.00267 | 8 |
| academic | institutions | 2.00267 | 8 |
| Department | Genentech | 2.00267 | 8 |
| Bioorganic | Department | 2.00267 | 8 |
| Bioorganic | Chemistry | 2.00267 | 8 |
| Chemistry | founder | 2.00267 | 8 |
| MCAL | founder | 2.00267 | 8 |
| MCAL | Therapeutics | 2.00267 | 8 |
| President | Tear | 2.00267 | 8 |
| Solutions | Tear | 2.00267 | 8 |
| Bioscience | Rogne | 2.00267 | 8 |
| SARcode | which | 2.00267 | 8 |
| discovered | which | 2.00267 | 8 |
| developed | discovered | 2.00267 | 8 |
| acquired | was | 2.00267 | 8 |
| Novartis | acquired | 2.00267 | 8 |
| 5B | Novartis | 2.00267 | 8 |